Humoral and t cell immune responses against sars-cov-2 after primary and homologous or heterologous booster vaccinations and breakthrough infection: a longitudinal cohort study in malaysia

HIGHLIGHTS

• who: Jolene Yin Ling Fu and colleagues from the Cohort Study in Malaysia Department of Medical Microbiology, Faculty of Medicine, University of Malaya have published the article: Humoral and T Cell Immune Responses against SARS-CoV-2 after Primary and Homologous or Heterologous Booster Vaccinations and Breakthrough Infection: A Longitudinal Cohort Study in Malaysia, in the Journal: Viruses 2023, 15, 844. of 31/Dec/2022
• what: Again, data on T_cell responses induced by the heterologous vaccine regime differ based on the number of doses, with two doses of the heterologous vaccine shown to induce better . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.